<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Hacker D</submitter><funding>Leona M and Harry B Helmsley Charitable Trust</funding><funding>Deutsche Forschungsgemeinschaft</funding><funding>NHLBI NIH HHS</funding><funding>National Research Foundation Singapore</funding><funding>Ludwig-Maximilians-Universität München</funding><pagination>2019-2034.e8</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12017801</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>32(11)</volume><pubmed_abstract>Exclusive enteral nutrition (EEN) is a first-line therapy for pediatric Crohn's disease (CD), but protective mechanisms remain unknown. We established a prospective pediatric cohort to characterize the function of fecal microbiota and metabolite changes of treatment-naive CD patients in response to EEN (German Clinical Trials DRKS00013306). Integrated multi-omics analysis identified network clusters from individually variable microbiome profiles, with Lachnospiraceae and medium-chain fatty acids as protective features. Bioorthogonal non-canonical amino acid tagging selectively identified bacterial species in response to medium-chain fatty acids. Metagenomic analysis identified high strain-level dynamics in response to EEN. Functional changes in diet-exposed fecal microbiota were further va</pubmed_abstract><journal>Cell host &amp; microbe</journal><pubmed_title>Exclusive enteral nutrition initiates individual protective microbiome changes to induce remission in pediatric Crohn's disease.</pubmed_title><pmcid>PMC12017801</pmcid><funding_grant_id>SFB 1371</funding_grant_id><funding_grant_id>R01 HL160862</funding_grant_id><funding_grant_id>2304-05970</funding_grant_id><funding_grant_id>395357507</funding_grant_id><funding_grant_id>2847</funding_grant_id><pubmed_authors>Heetmeyer J</pubmed_authors><pubmed_authors>Hacker D</pubmed_authors><pubmed_authors>Kohler N</pubmed_authors><pubmed_authors>Kleigrewe K</pubmed_authors><pubmed_authors>List M</pubmed_authors><pubmed_authors>Nie J</pubmed_authors><pubmed_authors>Smith BJ</pubmed_authors><pubmed_authors>Metwaly A</pubmed_authors><pubmed_authors>Pollard KS</pubmed_authors><pubmed_authors>Schwerd T</pubmed_authors><pubmed_authors>De Zen F</pubmed_authors><pubmed_authors>Riva A</pubmed_authors><pubmed_authors>Le Thi G</pubmed_authors><pubmed_authors>Neuhaus K</pubmed_authors><pubmed_authors>Heimes H</pubmed_authors><pubmed_authors>Holz H</pubmed_authors><pubmed_authors>Pauling JK</pubmed_authors><pubmed_authors>Mahapatra A</pubmed_authors><pubmed_authors>Meng C</pubmed_authors><pubmed_authors>Socas K</pubmed_authors><pubmed_authors>Haller D</pubmed_authors><pubmed_authors>Manz Q</pubmed_authors><pubmed_authors>Siebert K</pubmed_authors></additional><is_claimable>false</is_claimable><name>Exclusive enteral nutrition initiates individual protective microbiome changes to induce remission in pediatric Crohn's disease.</name><description>Exclusive enteral nutrition (EEN) is a first-line therapy for pediatric Crohn's disease (CD), but protective mechanisms remain unknown. We established a prospective pediatric cohort to characterize the function of fecal microbiota and metabolite changes of treatment-naive CD patients in response to EEN (German Clinical Trials DRKS00013306). Integrated multi-omics analysis identified network clusters from individually variable microbiome profiles, with Lachnospiraceae and medium-chain fatty acids as protective features. Bioorthogonal non-canonical amino acid tagging selectively identified bacterial species in response to medium-chain fatty acids. Metagenomic analysis identified high strain-level dynamics in response to EEN. Functional changes in diet-exposed fecal microbiota were further va</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Nov</publication><modification>2025-07-02T03:04:55.769Z</modification><creation>2025-07-02T03:04:55.769Z</creation></dates><accession>S-EPMC12017801</accession><cross_references><pubmed>39461337</pubmed><doi>10.1016/j.chom.2024.10.001</doi></cross_references></HashMap>